Skip to main content

Peer Review reports

From: EGR1 mediates MDR1 transcriptional activity regulating gemcitabine resistance in pancreatic cancer

Original Submission
11 Nov 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
28 Nov 2023 Reviewed Reviewer Report
7 Dec 2023 Reviewed Reviewer Report
9 Dec 2023 Reviewed Reviewer Report
18 Dec 2023 Reviewed Reviewer Report
1 Jan 2024 Author responded Author comments - Shanyu Qin
Resubmission - Version 3
1 Jan 2024 Submitted Manuscript version 3
7 Jan 2024 Author responded Author comments - Shanyu Qin
Resubmission - Version 4
7 Jan 2024 Submitted Manuscript version 4
9 Jan 2024 Reviewed Reviewer Report
10 Jan 2024 Reviewed Reviewer Report
11 Jan 2024 Reviewed Reviewer Report
20 Jan 2024 Reviewed Reviewer Report
2 Feb 2024 Author responded Author comments - Shanyu Qin
Resubmission - Version 5
2 Feb 2024 Submitted Manuscript version 5
3 Feb 2024 Author responded Author comments - Shanyu Qin
Resubmission - Version 6
3 Feb 2024 Submitted Manuscript version 6
3 Feb 2024 Author responded Author comments - Shanyu Qin
Resubmission - Version 7
3 Feb 2024 Submitted Manuscript version 7
14 Feb 2024 Reviewed Reviewer Report
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
14 Feb 2024 Editorially accepted
26 Feb 2024 Article published 10.1186/s12885-024-12005-2

You can find further information about peer review here.

Back to article page